Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Basel Medical Group Ltd ( (BMGL) ) has shared an announcement.
Basel Medical Group Ltd, a Singapore-based private healthcare group specializing in orthopedic, neurosurgical and general medical services, runs clinics across key commercial and residential hubs and has cultivated long-standing relationships with corporates in construction, marine and oil and gas. With more than two decades of operating history, it targets growth opportunities in Singapore and Southeast Asia driven by demographic trends, higher incomes, expanded insurance coverage and medical tourism.
On March 24, 2026, Basel Medical said it had received confirmation from Nasdaq that, following the filing of its amended 2025 Form 20-F on March 13, 2026, the exchange now deems the company in compliance with its periodic reporting requirement under Listing Rule 5250(c)(1). Resolution of the earlier filing deficiency removes a potential overhang on Basel Medical’s U.S. listing status and provides greater regulatory certainty for shareholders and other market participants.
More about Basel Medical Group Ltd
Basel Medical Group Ltd is a Singapore-based private healthcare provider focused on orthopedic and trauma services, sports medicine, orthopedic surgery and neurosurgical treatments, alongside executive health screening, occupational medicine, rehabilitation, mental and women’s health and general medical practice. It operates a network of clinics across multiple Singapore locations and serves a large corporate client base in construction, marine and oil and gas, positioning it to benefit from rising healthcare demand in Singapore and Southeast Asia.
Average Trading Volume: 47,277
Technical Sentiment Signal: Sell
Current Market Cap: $12.96M
For an in-depth examination of BMGL stock, go to TipRanks’ Overview page.